-
Webinar: The Greater Intermountain Node (GIN): Where We Were, Where We Are, and Where We Will Be (April 18, 12pm MT)
Presenter: Adam J. Gordon, MD, MPH, FACP, DFASAMApril 18, 2023 | 12:00-1:00 PM MST In this presentation, Dr. Gordon will describe the origination, present status, and future opportunities of the CTN Greater Intermountain Node (GIN). He will describe the mission and aims of GIN, as well as the three studies originating from the Node and six studies hosted by it. Dr. Gordon will emphasize the remarkable research and clinical collaboration across the University of Utah campus and greater Intermountain area. He will also discuss the robust mentored training of the GIN and look forward to how the GIN will evolve in the future. Connection information: Zoom ID: 931 8327 3330, passcode: parleys Posted April 3, 2023
-
Webinar: Injectable XR Buprenorphine: A Better Mousetrap or a Paradigm Shift in MOUD (April 6, Northeast Node)
Join the CTN Northeast Node on April 6, 2023 (12pm-1pm ET) for the latest in their Science Series: Injectable XR Buprenorphine: A Better Mousetrap or a Paradigm Shift in MOUD? with Eva Quirion, NP, PhD This presentation will explore the science behind extended release (XR) buprenorphine and field experiences in the use of XR buprenorphine in a primary care setting. This talk will also address ways to bring this medication to patients and if this treatment makes financial sense. 1.0 AMA PRA Category 1 CME available! Join the Zoom meeting here (no registration necessary)
-
News from the Northeast Node: Science Series Update
January 8, 2023 Northeast Node Science Series kicks off its ’22-23 Academic Year with an in-depth review of cannabis as a potential pharmacological adjunct to MOUD In November 2022, the Northeast Node welcomed Dr. Ziva Cooper of the UCLA Center for Cannabis & Cannabinoids to kick off the Node’s ’22-23 Academic Year Science Series. Dr. Cooper’s presentation, “Cannabis and Opioids: Promising pharmacology to address the opioid epidemic?” gave a brief overview of cannabis and the pharmacology of phytocannabinoids. Preclinical studies and randomized controlled trials have examined the potential for cannabinoids to modulate opioid effects and withdrawal symptoms, opioid abuse liability, and opioid analgesia. Dr. Cooper reviewed basic cannabinoid pharmacology and the state of evidence supporting the utility of cannabinoids for opioid use disorder and as an adjunct to opioids for pain management. The recorded presentation is available to all on the Northeast Node’s website. On Thursday, February 9, 2023 (12-1pm ET), the Science Series will welcome Craig R. Rush, PhD, from the University of Kentucky as he presents “Treating Stimulant Use Disorders in the Context of the Opioid Crisis: A Review.” Please email Northeast.Node.CTN@Dartmouth.edu to join the Science Series or Northeast Node mailing lists to stay in the know about the Science Series.
-
News from the Florida Node Alliance
Dr. José Szapocznik, Multiple PI of CTN’s Florida Node Alliance and Professor and Chair Emeritus at the Department of Public Health Sciences, of the University of Miami Miller School of Medicine, was elected to the Academy of Science, Engineering and Medicine of Florida (ASEMFL), an evidence-based scientific advisory body focused on providing expert advice to state government and other organizations on current and future challenges facing the world and Florida. Recognizing four and a half decades of important contributions to developing and testing interventions in the areas of mental health and drug abuse, ASEMFL elected Dr. Szapocznik for his “exemplary contributions to prevention science and globally impactful substance use prevention for youth and families.” Dr. Szapocznik’s formal induction will take place during the ASEMFL’s 2022 annual meeting in early November. Please join us in congratulating Dr. Szapocznik for this prestigious accomplishment!
